Key facts
- Waku Tea’s last known valuation is $6.0M (May 2022).
- It has raised $90K; the latest was Later Stage VC in Sep 2025.
- Notable investors include MassChallenge, Tonic Ventures, Babson College Venture Accelerator, Beckett Industries, Branch Venture Group — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Waku Tea
- ·The full record, as it builds
Funding rounds
No funding rounds for Waku Tea are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Waku Tea
Producer of prebiotic tea products intended to promote gut health and provide refreshing flavours. The company offers a platform that features caffeine-free herbal teas packed with functional herbs and flowers, which have low to no sugar and provide digestive benefits through their anti-inflammatory and analgesic properties, enabling health-conscious consumers to enjoy drinks while supporting improved immune response and proper digestive health for overall well-being.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Jamaica Plain, MA, United States
- Founded
- 2017
- Employees
- 3
- Website
- livewaku.com/
- Ownership
- Privately Held (backing)
Waku Tea doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Waku Tea shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Waku Tea in its N-PORT filings yet. We sweep new filings monthly.